Showing 6,109 results

Filters Content type: News, Editors' picks, About HIV Topic: HIV treatment

Treatment is recommended for all people living with HIV. It involves taking a combination of antiretroviral drugs. This stops the virus from replicating and allows the immune system to strengthen and fight infections.

History of HIV & AIDS

Antiretrovirals: A Success Story

Editor's pick
Poz
28 June 2016
New & experimental HIV treatments

The HIV Treatment Pipeline

Editor's pick
Poz
28 June 2016
New & experimental HIV treatments

PRO 140 antibody injections maintain viral suppression in phase 2 study

News
28 June 2016
New & experimental HIV treatments

Gilead’s single tablet regimen Odefsey receives European marketing approval for HIV treatment

Editor's pick
PharmaBiz
27 June 2016
HIV treatment

Taking Atripla Three Days a Week Maintains Undetectable HIV Viral Load, Pilot Study Finds

Editor's pick
The Body Pro
22 June 2016
Starting treatment

WHO confirms antiretroviral therapy reduces the risk of life-threatening HIV-related infections

Editor's pick
World Health Organization
22 June 2016
New & experimental HIV treatments

Investigational Integrase Inhibitor Bictegravir Safe and Effective Against HIV in Early Study

Editor's pick
The Body
21 June 2016
Treatment guidelines

China offers free antiviral therapy for HIV/AIDS

Editor's pick
Asia One
20 June 2016
Treatment guidelines

WHO releases second edition of Consolidated ARV guidelines

Editor's pick
World Health Organization
15 June 2016
Treatment interruptions

Fast Rebound After Treatment Interruption in 9 of 10 With Low HIV DNA Reservoir

Editor's pick
The Body PRO
13 June 2016
Treatment outcomes & life expectancy

Less frequent CD4 and viral load monitoring safe for people doing well on ART

News
13 June 2016
Treatment outcomes & life expectancy

Big increases in proportion of HIV-positive people in US treated with ART and with viral suppression

News
10 June 2016
African migrants

Sub-type C infection does not increase the risk of virologic failure when people are taking tenofovir-containing first-line ART

News
8 June 2016
New & experimental HIV treatments

Frontier Biotech's Long-acting HIV-1 Fusion Inhibitor Albuvirtide Meets 48-Week Primary Objective: Interim Results of a Phase 3 Trial

Editor's pick
Frontier Biotech press release
7 June 2016
Access to healthcare

Botswana gets GSK's modern HIV drug in largest ever Africa tender

Editor's pick
Reuters
3 June 2016
Bone & joint problems

Fearing Drugs’ Rare Side Effects, Millions Take Their Chances With Osteoporosis

Editor's pick
New York Times
2 June 2016
Bad science & bogus treatments

Kremlin Experts Blame Condoms for Russian HIV Epidemic

Editor's pick
Moscow Times
1 June 2016
Global health targets

Two million people with HIV started treatment in 2015

News
31 May 2016
Health monitoring in resource-limited settings

Very high levels of drug resistance seen in people experiencing first-line antiretroviral therapy failure in Kenya

News
31 May 2016
Pharmaceutical industry

A question of timing: A lawsuit claims Gilead Sciences could have developed a less-harmful version of its HIV treatment sooner

Editor's pick
Los Angeles Times
30 May 2016
Side effects

Rare but severe liver side-effects reported among South African patients starting efavirenz-based ART

News
27 May 2016
Hepatitis B

HIV/HBV co-infection linked to worse immune recovery and death, but tenofovir improves outcomes

News
23 May 2016
Starting treatment

In Option B+, side-effects and needing time to think are key reasons for not taking HIV medication

News
19 May 2016
Global health targets

Denmark shows first clear evidence of the success of treatment as prevention in gay men in a high income country

News
18 May 2016